<DOC>
	<DOC>NCT01264484</DOC>
	<brief_summary>The objective of this study is to assess long term safety and durability of the Advantage prosthetic heart valve.</brief_summary>
	<brief_title>ADVANTAGEÂ® Prosthetic Heart Valve Long-term Follow-up Trial</brief_title>
	<detailed_description>The objective of this study is to assess long term safety and durability of the Advantage prosthetic heart valve in patients who were already implanted with this device.</detailed_description>
	<mesh_term>Imidacloprid</mesh_term>
	<criteria>Participated in the ADVANTAGE Prosthetic Heart Valve Study in Herz und Diabeteszentrum (Bad Oeynhausen) or Deutsches Herzzentrum (Munich) Signed and dated patient data release form Available for followup High probability of nonadherence to physician's followup requirements</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2017</verification_date>
	<keyword>Advantage</keyword>
	<keyword>Non-interventional</keyword>
	<keyword>Post market release study</keyword>
	<keyword>Germany</keyword>
	<keyword>Treated with Advantage prosthetic heart valve</keyword>
</DOC>